There are ongoing clinical trials to help find a potent treatment option for weight loss and obesity
Researchers hope that non-peptide oral GLP-1 medications like orforglipron will be easier to produce, more affordable and more accessible to patients
PT 141 peptide : Deepening and Breakthrough in Scientific Exploration Faced with the potential application of Melanotan 2 in the field of sexual health, scientists quickly adjusted their research direction and began to explore its pharmacological mechanisms, safety, and efficacy in depth
267 Without an oxidative stress, TXNIP is in a bound state with Trx
According to the World Health Organization, obesity prevalence has nearly tripled since 1975, and it is associated with increased risks of developing chronic diseases such as type 2 diabetes, cardiovascular disease, and certain types of cancer
10.1016/j.lfs.2017.11.019 7 DevasaniK.KaulR.MajumdarA